Literature DB >> 16459429

Ethical considerations in research on preventing mother-to-child HIV transmission.

Shyamala Nataraj1.   

Abstract

Preventing mother to child transmission of HIV (PMTCT) is an issue that has come to the forefront in the global response to the HIV pandemic. This is particularly true for countries in sub-Saharan Africa and in Asia, which account for the largest proportion of people living with HIV. The relative success of PMTCT efforts to date have encouraged policy makers and donors alike to push for a rapid scaling up of the program in countries with a high prevalence of HIV. However, it is increasingly apparent that the relative success of the program has been at the expense of the rights and well-being of the mothers who are the primary recipients of the intervention. This article examines the nature and scope of the 'research enterprise' in PMTCT and shows how it has influenced intervention design and policy in India. It will also include the voices of 'target' women to convey the extent to which the research has impacted on their lives. Finally, this article indicates priorities for research that can help the situation of women as well as reduce MTCT of HIV.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2005        PMID: 16459429     DOI: 10.1007/BF03351440

Source DB:  PubMed          Journal:  Monash Bioeth Rev        ISSN: 1321-2753


  2 in total

1.  Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda.

Authors:  Cécile Alexandra Peltier; Gilles François Ndayisaba; Philippe Lepage; Johan van Griensven; Valériane Leroy; Christine Omes Pharm; Patrick Cyaga Ndimubanzi; Olivier Courteille; Vic Arendt
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

2.  Exploring how IBCLCs manage ethical dilemmas: a qualitative study.

Authors:  Joy Noel-Weiss; Betty Cragg; A Kirsten Woodend
Journal:  BMC Med Ethics       Date:  2012-07-23       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.